SARS-Cov-2
FDA delays decision on Moderna vaccine for adolescents over myocarditis risk
According to Moderna, the FDA said it will need more time to review the company’s request for an emergency use authorization of its COVID-19 vaccine in adolescents to further review the risk for myocarditis in this population.
COVID-19 vaccination more protective than previous infection, study finds
Another study has found that COVID-19 vaccination is more protective than a previous infection.
CDC: Immunocompromised adults may get fourth dose of COVID-19 vaccine
According to the guidance posted on the CDC website, people aged 18 years or older who are “moderately [or] severely immunocompromised” and who have received three doses of either one of the widely used messenger RNA vaccines may get a booster dose of those vaccines, or the Johnson & Johnson vaccine.
Counties with universities that participated in March Madness saw COVID-19 increases
Counties with universities participating in the NCAA’s March Madness basketball tournament saw an increase in COVID-19 cases beginning 8 days after the final game of participation, data published in JAMA Network Open showed.
Moderna says it will sell up to 110 million vaccine doses to African countries
Moderna announced Tuesday that it will sell up to 110 million doses of its COVID-19 vaccine at the lowest tiered price to the African Union in a deal the company said was partly facilitated by the White House.
Biden signs order loosening international travel rules for vaccinated passengers
President Joe Biden on Monday ordered that restrictions on international travel to the United States be based on the vaccination status of travelers, not their country of origin.
Americans ‘may choose’ their own booster, CDC director emphasizes
The director of the CDC signed off on her vaccine advisory committee’s recommendations to allow booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines and emphasized that Americans can now choose their own booster shot.
CDC committee unanimously recommends Moderna, J&J boosters
A CDC advisory committee on Thursday unanimously recommended booster doses of the COVID-19 vaccines made by Moderna and Johnson & Johnson, aligning with an FDA authorization issued this week.
Pfizer, BioNTech report positive phase 3 data on COVID-19 booster shot
Pfizer and BioNTech said Thursday that a booster dose of their COVID-19 vaccine was safe and demonstrated a relative efficacy of more than 95% compared with not receiving a booster shot, according to findings from a phase 3 trial.
Should COVID-19 vaccination be mandated in schools?
As the COVID-19 pandemic progresses, the emergence of more transmissible variants has coincided with an increase in the proportion of U.S. cases reported among children.